Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung

Matthew C. Duch, G. R.Scott Budinger, Yu Teng Liang, Saul Soberanes, Daniela Urich, Sergio E. Chiarella, Laura A. Campochiaro, Angel Gonzalez, Navdeep S. Chandel, Mark C. Hersam*, Gökhan M. Mutlu

*Corresponding author for this work

Research output: Contribution to journalArticle

351 Scopus citations

Abstract

To facilitate the proposed use of graphene and its derivative graphene oxide (GO) in widespread applications, we explored strategies that improve the biocompatibility of graphene nanomaterials in the lung. In particular, solutions of aggregated graphene, Pluronic dispersed graphene, and GO were administered directly into the lungs of mice. The introduction of GO resulted in severe and persistent lung injury. Furthermore, in cells GO increased the rate of mitochondrial respiration and the generation of reactive oxygen species, activating inflammatory and apoptotic pathways. In contrast, this toxicity was significantly reduced in the case of pristine graphene after liquid phase exfoliation and was further minimized when the unoxidized graphene was well-dispersed with the block copolymer Pluronic. Our results demonstrate that the covalent oxidation of graphene is a major contributor to its pulmonary toxicity and suggest that dispersion of pristine graphene in Pluronic provides a pathway for the safe handling and potential biomedical application of two-dimensional carbon nanomaterials.

Original languageEnglish (US)
Pages (from-to)5201-5207
Number of pages7
JournalNano letters
Volume11
Issue number12
DOIs
StatePublished - Dec 14 2011

Keywords

  • Graphene
  • biocompatibility
  • graphene oxide
  • pluronic
  • poloxamer

ASJC Scopus subject areas

  • Bioengineering
  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering

Fingerprint Dive into the research topics of 'Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung'. Together they form a unique fingerprint.

  • Cite this

    Duch, M. C., Budinger, G. R. S., Liang, Y. T., Soberanes, S., Urich, D., Chiarella, S. E., Campochiaro, L. A., Gonzalez, A., Chandel, N. S., Hersam, M. C., & Mutlu, G. M. (2011). Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano letters, 11(12), 5201-5207. https://doi.org/10.1021/nl202515a